<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16985</article-id><article-id pub-id-type="doi">10.25208/vdv16985</article-id><article-id pub-id-type="edn">MPPUQS</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>GUIDELINES FOR PRACTITIONERS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>В ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Experience of using a multi-component serum for hair loss in androgenetic alopecia in women</article-title><trans-title-group xml:lang="ru"><trans-title>Опыт применения многокомпонентной сыворотки от выпадения волос при андрогенной алопеции у женщин</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1674-3007</contrib-id><contrib-id contrib-id-type="spin">5601-1201</contrib-id><name-alternatives><name xml:lang="en"><surname>Gallyamova</surname><given-names>Yulia A.</given-names></name><name xml:lang="ru"><surname>Галлямова</surname><given-names>Юлия Альбертовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Medicine), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>derma2006@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-9870-0237</contrib-id><name-alternatives><name xml:lang="en"><surname>Mareeva</surname><given-names>Anastasia N.</given-names></name><name xml:lang="ru"><surname>Мареева</surname><given-names>Анастасия Николаевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Сand. Sci. (Medicine), Dermatovenereologist</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач-дерматовенеролог</p></bio><email>nastasya_66@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Medical Academy of Postgraduate Education</institution></aff><aff><institution xml:lang="ru">Российская медицинская академия непрерывного профессионального образования</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Innovative Institute of Hair and Cosmetology LLC</institution></aff><aff><institution xml:lang="ru">ООО «Инновационный институт волос и косметологии»</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-07-21" publication-format="electronic"><day>21</day><month>07</month><year>2026</year></pub-date><pub-date date-type="pub" iso-8601-date="2026-08-27" publication-format="electronic"><day>27</day><month>08</month><year>2026</year></pub-date><volume>102</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>69</fpage><lpage>76</lpage><history><date date-type="received" iso-8601-date="2026-03-29"><day>29</day><month>03</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-06-29"><day>29</day><month>06</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2026, Gallyamova Y.A., Mareeva A.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2026, Галлямова Ю.А., Мареева А.Н.</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="en">Gallyamova Y.A., Mareeva A.N.</copyright-holder><copyright-holder xml:lang="ru">Галлямова Ю.А., Мареева А.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/16985">https://vestnikdv.ru/jour/article/view/16985</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND: </bold>Androgenetic alopecia is a widespread disorder that presents therapeutic challenges due to patients' inflated expectations, low treatment compliance associated with inconvenient topical application, and concerns regarding adverse effects. Therefore, investigating the efficacy of non-drug multi-component agents for managing hair loss and stimulating hair growth appears highly relevant.</p> <p><bold>AIM:</bold> Evaluation of the efficacy of a corrective and stimulating serum combining a minoxidil derivative and high-concentration niacinamide in women with androgenetic alopecia.</p> <p><bold>METHODS: </bold>The study involved 38 female patients who applied the serum daily for 4 months. The outcomes were assessed clinically and using phototrichogram analysis.</p> <p><bold>RESULTS: </bold>Upon completion of the treatment course, clinical recovery was observed in 25 patients (65.8%), significant improvement — in 4 (10.5%), and improvement — in 3 (7.9%). No effect was reported in 6 cases (15.8%). The proportion of telogen hair normalized (≤ 10%) in 27 women (71.1%).</p> <p><bold>CONCLUSION: </bold>The multi-component serum applied in the study showed high efficacy and good tolerability in the treatment of female androgenetic alopecia. Its ease of use promotes better treatment compliance, allowing this product to be recommended for long-term application in the comprehensive management of this condition.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Андрогенная алопеция — широко распространённое заболевание, вызывающее сложности в подборе терапии из-за завышенных ожиданий пациентов, низкой приверженности лечению, связанной с неудобством применения наружных средств, а также опасений побочных эффектов. В связи с этим актуальным представляется исследование эффективности нелекарственных многокомпонентных средств для коррекции выпадения и стимуляции роста волос.</p> <p><bold>Цель.</bold> Оценка эффективности корригирующей и стимулирующей сыворотки, представляющей собой комбинацию производной миноксидила и ниацинамида в высокой концентрации, у женщин с андрогенной алопецией.</p> <p><bold>Методы.</bold> В исследовании участвовали 38 пациенток, применявших сыворотку ежедневно в течение 4 мес. Результаты оценивали клинически и методом фототрихограммы.</p> <p><bold>Результаты. </bold>По итогам курса клиническое выздоровление зафиксировано у 25 пациенток (65,8%), значительное улучшение — у 4 (10,5%), улучшение — у 3 (7,9%). Отсутствие эффекта отмечено в 6 случаях (15,8%). Доля телогеновых волос нормализовалась (≤ 10%) у 27 женщин (71,1%).</p> <p><bold>Заключение.</bold> Использованная в исследовании многокомпонентная сыворотка продемонстрировала высокую эффективность и хорошую переносимость в терапии андрогенной алопеции у женщин. Удобство применения способствует повышению приверженности лечению, что позволяет рекомендовать это средство для длительного использования в комплексной коррекции данного состояния.</p></trans-abstract><kwd-group xml:lang="en"><kwd>androgenetic alopecia</kwd><kwd>hair loss serum</kwd><kwd>hair loss</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>андрогенная алопеция</kwd><kwd>сыворотка от выпадения волос</kwd><kwd>выпадение волос</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Lolli F, Pallotti F, Rossi A, Fortuna MC, et al. Androgenetic alopecia: a review. Endocrine. 2017;57(1):9–17. doi: 10.1007/s12020-017-1280-y EDN: TKAUEV</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Piraccini BM, Alessandrini A. Androgenetic alopecia. G Ital Dermatol Venereol. 2014;149(1):15–24.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Kaliyadan F, Nambiar A, Vijayaraghavan S. Androgenetic alopecia: an update. Indian J Dermatol Venereol Leprol. 2013;79(5):613–625. doi: 10.4103/0378-6323.116730</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Chitalia J, Dhurat R, Goren A, et al. Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent. Dermatol Ther. 2018;31(6):e12688. doi: 10.1111/dth.12688</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Piraccini B, Starace M, Guarrera M, et al. Efficacy and tolerability of 5% minoxidil solution (Carexidil®) in male and female androgenetic alopecia: a 6-month open multicentric study. G Ital Dermatol Venereol. 2011;146(5):1–8. [In Italian].</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Camacho FM, Camacho-Serrano F, Moreno-Giminez JC, et al. Treatment of alopecias of male and female patterns. Clinical efficacy of aminexil and SP94 in two surveys of 180 patients, men and women. Med Cutan Iber Lat Am. 2013;41(1):18–33. doi: 10.4464/MC.2013.41.1.5046</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Loussouarn G, Courtois M, Hourseau C, Lang G. A new approach to the prevention and cosmetic treatment of alopecia: aminexil. BEDC. 1997;5(7):1–6.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Mahé YF, Buan B, Bernard BA. A minoxidil-related compound lacking a C6 substitution still exhibits strong anti-lysyl hydroxylase activity in vitro. Skin Pharmacol. 1996;9(3):177–183. doi: 10.1159/000211413</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ayeleso TB, Matumba MG, Mukwevho E. Oleanolic acid and its derivatives: biological activities and therapeutic potential in chronic diseases. Molecules. 2017;22(11):1915. doi: 10.3390/molecules22111915</mixed-citation></ref></ref-list></back></article>
